Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs

1. BarnesPJ

CelliBR

2009 Systemic manifestations and comorbidities of COPD. Eur Respir J 33 1165 1185

2. ManninoDM

ThornD

SwensenA

HolguinF

2008 Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J 32 962 969

3. CalverleyPM

AndersonJA

CelliB

FergusonGT

JenkinsC

2007 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 775 789

4. GanWQ

ManSF

SenthilselvanA

SinDD

2004 Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 574 580

5. SinDD

LeungR

GanWQ

ManSP

2007 Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 7 13

6. ItoK

BarnesPJ

2009 COPD as a disease of accelerated lung aging. Chest 135 173 180

7. FabbriLM

RabeKF

2007 From COPD to chronic systemic inflammatory syndrome? Lancet 370 797 799

8. SabitR

BoltonCE

EdwardsPH

PettitRJ

EvansWD

2007 Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 1259 1265

9. MaclayJD

McAllisterDA

MillsNL

PatersonFP

LudlamCA

2009 Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180 513 520

10. RuttenFH

VonkenEJ

CramerMJ

MoonsKG

VelthuisBB

2008 Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. Am Heart J 156 506 512

11. WatzH

WaschkiB

KirstenA

MullerKC

KretschmarG

2009 The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 136 1039 1046

12. LamKB

JordanRE

JiangCQ

ThomasGN

MillerMR

2010 Airflow obstruction and the metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur Respir J 35 317 323

13. JorgensenNR

SchwarzP

2008 Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 14 122 127

14. HungWW

WisniveskyJP

SiuAL

RossJS

2009 Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180 134 137

15. YoungRP

HopkinsRJ

ChristmasT

BlackPN

MetcalfP

2009 COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 34 380 386

16. TurnerMC

ChenY

KrewskiD

CalleEE

ThunMJ

2007 Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176 285 290

17. AnthonisenNR

SkeansMA

WiseRA

ManfredaJ

KannerRE

2005 The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142 233 239

18. CelliB

DecramerM

KestenS

LiuD

MehraS

2009 Mortality in the 4 Year Trial of Tiotropium (UPLIFT) in Patients with COPD. Am J Respir Crit Care Med 180 948 955